Published in Am J Gastroenterol on May 01, 2000
Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol (2009) 2.63
The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease. Am J Gastroenterol (2015) 2.51
Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol (2009) 2.24
Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut (2005) 2.20
Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis. Sleep Med (2009) 1.75
Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health Study. Clin Gastroenterol Hepatol (2012) 1.74
Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut (2006) 1.66
Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease. Aliment Pharmacol Ther (2013) 1.64
Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut (2001) 1.46
A randomized controlled trial of mindfulness-based stress reduction to prevent flare-up in patients with inactive ulcerative colitis. Digestion (2014) 1.46
Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature. Dig Dis Sci (2014) 1.41
A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol (2013) 1.40
Radical induction theory of ulcerative colitis. World J Gastroenterol (2005) 1.28
Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemiol Ment Health (2006) 1.26
Increased antigen and bacterial uptake in follicle associated epithelium induced by chronic psychological stress in rats. Gut (2004) 1.13
Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay. J Physiol (2007) 1.05
Epithelia under metabolic stress perceive commensal bacteria as a threat. Am J Pathol (2004) 1.05
Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy. Int J Colorectal Dis (2013) 1.00
Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther (2013) 0.94
Life-event stress induced by the Great East Japan Earthquake was associated with relapse in ulcerative colitis but not Crohn's disease: a retrospective cohort study. BMJ Open (2013) 0.94
Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J Gastroenterol (2007) 0.93
Comorbidity in inflammatory bowel disease. World J Gastroenterol (2011) 0.93
Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci (2014) 0.92
Reconsidering the methodology of "stress" research in inflammatory bowel disease. J Crohns Colitis (2008) 0.91
Behavioral interventions may prolong remission in patients with inflammatory bowel disease. Behav Res Ther (2010) 0.89
Neurological and cellular regulation of visceral hypersensitivity induced by chronic stress and colonic inflammation in rats. Neuroscience (2013) 0.89
Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10-/- mice. Inflamm Bowel Dis (2013) 0.85
The potential role of a self-management intervention for ulcerative colitis: a brief report from the ulcerative colitis hypnotherapy trial. Biol Res Nurs (2011) 0.85
Pain management in patients with inflammatory bowel disease: insights for the clinician. Therap Adv Gastroenterol (2012) 0.84
Validation of the Spanish versions of the long (26 items) and short (12 items) forms of the Self-Compassion Scale (SCS). Health Qual Life Outcomes (2014) 0.84
Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease. World J Gastroenterol (2014) 0.84
A comparison of self-perceived health status in inflammatory bowel disease and irritable bowel syndrome patients from a Canadian national population survey. Can J Gastroenterol (2008) 0.84
Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis. World J Gastroenterol (2013) 0.83
Psychobiological subtypes of ulcerative colitis: pANCA status moderates the relationship between disease activity and psychological distress. Am J Gastroenterol (2006) 0.83
Current concept of pathophysiological understanding and natural course of ulcerative colitis. Langenbecks Arch Surg (2004) 0.83
Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: implications for clinical management. Dig Dis Sci (2015) 0.83
Association of Inflammatory Bowel Disease (IBD) with Depressive Symptoms in the United States Population and Independent Predictors of Depressive Symptoms in an IBD Population: A NHANES Study. Gut Liver (2017) 0.81
Reassessment of the psychometric characteristics and factor structure of the 'Perceived Stress Questionnaire' (PSQ): analysis in a sample of dental students. PLoS One (2014) 0.81
How to predict clinical relapse in inflammatory bowel disease patients. World J Gastroenterol (2016) 0.81
Optimizing management of Crohn's disease within a project management framework: results of a pilot study. Inflamm Bowel Dis (2011) 0.80
Psychological aspects of inflammatory bowel disease. J Gastroenterol (2007) 0.80
Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther (2016) 0.80
Stress-related changes in oesophageal permeability: filling the gaps of GORD? Gut (2007) 0.79
[Psychophysiology of visceral pain]. Schmerz (2014) 0.79
IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol (2016) 0.79
Effectiveness of disease-specific cognitive-behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD). BMJ Open Gastroenterol (2016) 0.78
Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis. World J Gastroenterol (2005) 0.78
Health-related quality of life in pediatric ulcerative colitis patients on conventional medical treatment compared to those after restorative proctocolectomy. Int J Colorectal Dis (2012) 0.78
Chronic subordinate colony housing paradigm: a mouse model to characterize the consequences of insufficient glucocorticoid signaling. Front Psychiatry (2015) 0.78
Factor structures of the Swedish Version of the RFIPC: Investigating the Validity of Measurements of IBD Patients' Worries and Concerns. Gastroenterology Res (2010) 0.77
Sensory denervation reduces visceral hypersensitivity in adult rats exposed to chronic unpredictable stress: evidences of neurogenic inflammation. Dig Dis Sci (2008) 0.77
Re: Levenstein et al.--Ulcerative colitis in remission and stress. Am J Gastroenterol (2000) 0.77
Perceived stress latent factors and the burnout subtypes: a structural model in dental students. PLoS One (2014) 0.76
Once daily versus conventional dosing of pH-dependent mesalamine long-term to maintain quiescent ulcerative colitis: Preliminary results from a randomized trial. Patient Prefer Adherence (2008) 0.76
Influence of environmental factors on the onset and course of inflammatory bowel disease. World J Gastroenterol (2016) 0.75
Inflammatory bowel disease and anxiety: links, risks, and challenges faced. Clin Exp Gastroenterol (2015) 0.75
Beneficial Effects of Maprotiline in a Murine Model of Colitis in Normal and Reserpinised Depressed Rats. Int Sch Res Notices (2014) 0.75
Assessment of Disease Severity and Role of Cytomegalo Virus Infection in Patients with Ulcerative Colitis. J Clin Diagn Res (2017) 0.75
The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders. Curr Neuropharmacol (2016) 0.75
Stress as a Trigger for Relapses in IBD: A Case-Crossover Study. Gastroenterology Res (2013) 0.75
Melatonin improves experimental colitis with sleep deprivation. Int J Mol Med (2015) 0.75
Microbiota alteration is associated with the development of stress-induced despair behavior. Sci Rep (2017) 0.75
Acute onset of ulcerative colitis following an operation for sigmoid colon cancer. J Gastroenterol (2006) 0.75
Depressive Symptoms and Quality of Life in the Patients of Inflammatory Bowel Disease. Gut Liver (2017) 0.75
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Development of the Perceived Stress Questionnaire: a new tool for psychosomatic research. J Psychosom Res (1993) 2.96
The International Personality Disorder Examination. The World Health Organization/Alcohol, Drug Abuse, and Mental Health Administration international pilot study of personality disorders. Arch Gen Psychiatry (1994) 2.89
Predicting body cell mass with bioimpedance by using theoretical methods: a technological review. J Appl Physiol (1985) (1997) 2.28
Topical butyrate for acute radiation proctitis: randomised, crossover trial. Lancet (2000) 2.09
Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol (1994) 1.95
Air pollution and hospital admissions for respiratory conditions in Rome, Italy. Eur Respir J (2001) 1.87
Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis. Gastroenterology (1995) 1.74
Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission. Aliment Pharmacol Ther (2002) 1.66
Indirect estimates of lung cancer death rates in Italy not attributable to active smoking. Epidemiology (1993) 1.65
Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study. Aliment Pharmacol Ther (2005) 1.52
Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin. Ital J Gastroenterol Hepatol (1998) 1.50
Multifrequency bioelectrical impedance analysis in women with a normal and hypertensive pregnancy. Am J Clin Nutr (2000) 1.48
Coronary artery bypass graft surgery: socioeconomic inequalities in access and in 30 day mortality. A population-based study in Rome, Italy. J Epidemiol Community Health (2000) 1.46
Frequency and prognostic significance of silent coronary artery disease in patients with cerebral ischemia undergoing carotid endarterectomy. Am J Cardiol (1992) 1.46
Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial. Dig Liver Dis (2002) 1.44
An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol (1996) 1.44
Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis. Dig Liver Dis (2006) 1.42
Food habits in a southern Italian town (Nicotera) in 1960 and 1996: still a reference Italian Mediterranean diet? Diabetes Nutr Metab (2001) 1.41
Psychologic predictors of duodenal ulcer healing. J Clin Gastroenterol (1996) 1.40
Multifrequency impedance in the assessment of body water losses during dialysis. Ren Physiol Biochem (1995) 1.39
Reversible sustained increase of gastrin and gastric acid secretion in a subgroup of duodenal ulcer patients on long-term treatment with H2 antagonists. J Clin Gastroenterol (1991) 1.39
Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis. Ann Intern Med (1999) 1.38
Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes. Ital J Gastroenterol Hepatol (1998) 1.37
Antibodies to Mycobacterium paratuberculosis-specific protein antigens in Crohn's disease. Clin Exp Immunol (1992) 1.35
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment Pharmacol Ther (2006) 1.33
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32
Efficacy of gluten-free diet alone on recovery from iron deficiency anemia in adult celiac patients. Am J Gastroenterol (2001) 1.31
Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther (1995) 1.29
Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients. Dig Liver Dis (2002) 1.28
Anisakis infestation: a case of acute abdomen mimicking Crohn's disease and eosinophilic gastroenteritis. Dig Liver Dis (2005) 1.27
Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database Syst Rev (2000) 1.24
Crohn's disease: the case for bacteria. Ital J Gastroenterol Hepatol (1999) 1.22
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther (1994) 1.22
The validity of predicted body fat percentage from body mass index and from impedance in samples of five European populations. Eur J Clin Nutr (2001) 1.19
Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther (2002) 1.19
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther (2007) 1.18
Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study. Am J Gastroenterol (2001) 1.17
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology (1999) 1.17
Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterology (1995) 1.16
Disease association of antibodies to human and mycobacterial hsp70 and hsp60 stress proteins. Clin Exp Immunol (1992) 1.13
Orbital pain and unruptured carotid-posterior communicating artery aneurysms: the role of sensory fibers of the third cranial nerve. Acta Neurochir (Wien) (1993) 1.08
Dissecting aneurysms of the basilar artery. Neurosurgery (1995) 1.08
Hemodynamic mechanism in the angiographic disappearance of ruptured cerebral aneurysm. Surg Neurol (1984) 1.07
Subarachnoid hemorrhage: frequency and severity of cardiac arrhythmias. A survey of 70 cases studied in the acute phase. Stroke (1987) 1.07
Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol (1998) 1.05
Comparison of nedocromil sodium and sodium cromoglycate administered by pressurized aerosol, with and without a spacer device in exercise-induced asthma in children. Eur Respir J (1993) 1.04
A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum. Clin Exp Immunol (1989) 1.03
How fat is obese? Acta Diabetol (2003) 1.03
Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group). Dig Dis Sci (2000) 1.03
Analytic assessment of the various bioimpedance methods used to estimate body water. J Appl Physiol (1985) (1998) 1.02
Dissecting aneurysms of the vertebrobasilar system: study of 16 cases. Surg Neurol (1994) 1.02
Prediction of surgery for obstruction in Crohn's ileitis. A study of 64 patients. Dig Dis Sci (1987) 1.01
Holter detection of cardiac arrhythmias in intracranial subarachnoid hemorrhage. Am J Cardiol (1987) 0.99
Salivary-specific immunoglobulin G in the diagnosis of Helicobacter pylori infection in dyspeptic patients. Am J Gastroenterol (1995) 0.98
Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther (2003) 0.97
Socio-demographic differences in adherence to evidence-based drug therapy after hospital discharge from acute myocardial infarction: a population-based cohort study in Rome, Italy. J Clin Pharm Ther (2011) 0.97
Relationship between clinical and laboratory parameters and length of lesion in Crohn's disease of small bowel. Dig Dis Sci (1984) 0.97
Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most. J Clin Gastroenterol (1988) 0.96
Predicting fat-free mass in children using bioimpedance analysis. Acta Diabetol (2003) 0.96
Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut (1985) 0.94
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003. Int J Colorectal Dis (2001) 0.94
Hemifield pattern-reversal visual evoked potentials (VEPs) in retrochiasmal lesions with homonymous visual field defect. Ital J Neurol Sci (1986) 0.92
Melanosis of the rectum in patients with chronic constipation. Dis Colon Rectum (1985) 0.91
Involvement of the corporal mucosa and related changes in gastric acid secretion characterize patients with iron deficiency anaemia associated with Helicobacter pylori infection. Aliment Pharmacol Ther (2001) 0.91
Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study. Dig Dis Sci (2000) 0.91
Giant calcified thoracic herniated disc: considerations aiming a proper surgical strategy. J Neurosurg Sci (2009) 0.90
Hysterectomy and socioeconomic position in Rome, Italy. J Epidemiol Community Health (2002) 0.90
Cardiologic complications of subarachnoid hemorrhage. J Neurosurg Sci (1998) 0.89
Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen. Am J Gastroenterol (1994) 0.89
Cerebral ischemia and asymptomatic coronary artery disease: a prospective study of 83 patients. Stroke (1987) 0.89
HIV IgM antibodies in risk groups who are seronegative on ELISA testing. Lancet (1986) 0.89
Comparison of different techniques to measure body composition in moderately active adolescents. Br J Sports Med (1998) 0.88
HIV risk-related behaviors among injection drug users in Rome: differences between 1990 and 1992. Am J Public Health (1995) 0.88
[The quality of medical records: a retrospective study in Lazio Region, Italy]. Ann Ig (2004) 0.87